• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[Effects of combination chemotherapy of MCNU with various anti-cancer agents].

作者信息

Machida S, Ito Y, Hoshino A

出版信息

Gan To Kagaku Ryoho. 1985 Feb;12(2):298-302.

PMID:3918506
Abstract

Combination chemotherapy using the water-soluble nitrosourea MCNU with various anti-cancer agents was studied using L1210 leukemia and P388 leukemia. In titration experiments MCNU showed remarkable antitumor effects at doses from 5 mg/kg to 80 mg/kg, producing numbers of 60-day survivors with L1210 leukemia. In L1210 leukemia, respective combinations of MCNU with the antimetabolites, MTX, 6-MP, 6-TG, MCNU, 5-FU and Cyclo-C showed enhanced antitumor effects. MCNU combined with each of ADR, MMC and CPM also showed marked anti-tumor effects with 60-day survivors. In P388 leukemia MCNU combined with each of ADR, MMC, VDS and CPM produced strong anti-tumor effects with numbers of 60-day survivors. In the results of these combinations, especially the combinations of MCNU + 5-FU in L1210 leukemia and MCNU + CPM in both L1210 and P388 leukemia, a significant increase in mean survival time was achieved. These combinations also produced many 60-day survivors which were considered to be due to the synergistic antitumor effects of the combined drugs.

摘要

相似文献

1
[Effects of combination chemotherapy of MCNU with various anti-cancer agents].
Gan To Kagaku Ryoho. 1985 Feb;12(2):298-302.
2
[Effect of combination chemotherapy of nitrosourea MCNU with various anti-tumor agents].
Gan To Kagaku Ryoho. 1984 Jun;11(6):1315-23.
3
[Experimental combination chemotherapy of YNK01, a novel analog of cytarabine, with other antitumor agents].
Gan To Kagaku Ryoho. 1990 Jul;17(7):1351-6.
4
Experimental combination chemotherapy of pirarubicin with various antitumor drugs against P388 murine leukemia.
Cancer Biochem Biophys. 1994 Sep;14(2):137-49.
5
Mitomycin C combination therapy against murine tumor systems. Effectiveness with cyclophosphamide and methotrexate.丝裂霉素C联合疗法对小鼠肿瘤系统的作用。与环磷酰胺和甲氨蝶呤联合使用的疗效。
Cancer. 1983 Feb 15;51(4):600-5. doi: 10.1002/1097-0142(19830215)51:4<600::aid-cncr2820510408>3.0.co;2-c.
6
Potentiation by vitamin A of the action of anticancer agents against murine tumors.维生素A对抗癌剂抗小鼠肿瘤作用的增强作用。
Jpn J Cancer Res. 1985 Sep;76(9):887-94.
7
[Comparative effect of administration schedules on the antitumor activities of 3 water-soluble nitrosoureas, ACNU, GANU and MCNU against L1210 leukemia].
Gan To Kagaku Ryoho. 1983 May;10(5):1354-62.
8
Synergistic action of 2-chlorodeoxyadenosine and cyclophosphamide on murine leukemias L1210 and P388.2-氯脱氧腺苷与环磷酰胺对小鼠白血病L1210和P388的协同作用。
Acta Haematol Pol. 1993;24(2):177-82.
9
[Experimental studies on oral administration of nitrosourea anti-tumor agent, MCNU].[口服亚硝基脲类抗肿瘤药甲环亚硝脲的实验研究]
Gan To Kagaku Ryoho. 1984 Jul;11(7):1492-500.
10
Potentiation of therapeutic effects of 3-[(4-amino-2-methyl-5-pyrimidinyl)methyl]-1-(2-chloroethyl)-1-nitrosourea hydrochloride by 6-thioguanine in mouse tumor systems: comparison with other antimetabolites.
Gan. 1980 Feb;71(1):60-72.